Deborah Morosini Prelude Therapeutics Inc (PRLD) insider trading activity
Deborah Morosini is EVP, Chief of Clinical Affairs of Prelude Therapeutics Inc. Currently has a direct ownership of 444 shares of PRLD, which is worth approximately $577. The most recent transaction as insider was on Dec 15, 2021, when has been sold 28,751 shares (Common Stock) at a price of $13.0 per share, resulting in proceeds of $373,763. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
444
0%
3M change
0%
12M change
Total Value Held
$577
Deborah Morosini Transaction History
DM
Deborah Morosini
EVP, Chief of Clinical Affairs
Wilmington, DE